- $178 BnWorld market, 2023
- $281.8 BnProjected, 2033
- 4.7%Growth a year (CAGR)
- 297Active clinical trials worldwide
Largest countries
Market size in 2023 · growth a year to 2033
-
1
US
$74.8 Bn
2.7% a year · 42% of the world -
2
China
$14.3 Bn
6.2% a year · 8% of the world -
3
Canada
$14.2 Bn
4.7% a year · 8% of the world -
4
Japan
$11.1 Bn
5.2% a year · 6.2% of the world -
5
Germany
$6.5 Bn
2.9% a year · 3.7% of the world -
6
France
$4.9 Bn
3.7% a year · 2.8% of the world -
7
UK
$4.6 Bn
2.7% a year · 2.6% of the world -
8
Brazil
$4.5 Bn
5.7% a year · 2.5% of the world -
9
Italy
$4.3 Bn
4.2% a year · 2.4% of the world -
10
Ecuador
$3.6 Bn
5.3% a year · 2% of the world
Most clinical trials
Active trials by country (ClinicalTrials.gov)
See every trial on ClinicalTrials.gov (opens in a new tab)
Australia
EgyptOver The Counter (OTC) Drugs by country and region
Spain
India
Saudi Arabia
Mexico
South Africa
UAE
Philippines
Malaysia
Hong Kong
Singapore
Thailand
Kenya
New Zealand
Russia"–" means we have no size for that place yet. 2033 values are projected from the 2023 size and the CAGR. Regions count only the countries we report on for trials.
Latest research 6,499 papers since 2021
- Evaluation of Interventions and the Impact of Pharmacist Consultations on the Management of Minor Ailments in Brazil. Journal of evaluation in clinical practice, 2026
- Factors Associated with Self-Medication Among Pregnant Women Attending Maternal and Child Health Centers in Peru: A Cross-Sectional Study. International journal of women's health, 2026
- Cost-effectiveness Analysis of SUTAB or SUFLAVE Versus Polyethylene Glycol-Electrolyte Solution or Over-the-Counter Bowel Preparations for Screening Colonoscopy. Journal of clinical gastroenterology, 2026
- Type of medication for opioid use disorder is associated with distinct risk profiles among an urban community sample of people who use opioids. Research square, 2026
- Medication literacy and its associated factors among children aged 8-17 years in China: a cross-sectional network analysis. Journal of pediatric nursing, 2026
Compare Over The Counter (OTC) Drugs side by side
Key companies in Over The Counter (OTC) Drugs
Bayer AG
Boehringer Ingelheim International GmbH
Dr Reddy’s Laboratories
GSK
Johnson & Johnson Services Inc
Novartis AG
Perrigo Company PLC
Sanofi S.A
Reckitt Benckiser Group PLC
Takeda Pharmaceutical Company Ltd
Quick answers
How big is the Over The Counter (OTC) Drugs market?
The world Over The Counter (OTC) Drugs market was worth about $178 Bn in 2023 and is projected to reach $281.8 Bn by 2033, growing 4.7% a year (CAGR).
Which country has the largest Over The Counter (OTC) Drugs market?
The US is the largest of the 24 countries we cover, at $74.8 Bn in 2023. India grows fastest, at 7.7% a year.
How many clinical trials are running in Over The Counter (OTC) Drugs?
ClinicalTrials.gov lists 297 active trials worldwide (recruiting, about to start or running), most of them in the US, as of 10 Nov 2026.
How much research is published on Over The Counter (OTC) Drugs?
PubMed lists about 6,499 papers on the topic since 2021.
Sources: market size and growth: Acuitas Health Analytics research (2023 base year, forecasts to 2033). Trials: ClinicalTrials.gov. Research: PubMed (US National Library of Medicine). Fetched 10 Nov 2026. Trials and papers are found by search words, so counts are a guide.